Why Rigaku Holdings (TSE:268A) Shares Climbed And Investors Are Taking Another Look
Rigaku Holdings (TSE:268A) has drawn fresh investor attention after Rigaku Corporation introduced the CT Lab HR160, a high resolution X ray CT system tailored to batteries, semiconductors, and electronic components.
The CT Lab HR160 launch comes as Rigaku Holdings’ share price has been volatile over recent months. A 1-day share price return of 4.98% and 7-day share price return of 4.92% contrast with a 30-day share price return that fell 21.42% and a 90-day share price return that declined 35.77%. The year-to-date share price return is 36.70% and the 1-year total shareholder return is 87.97%, suggesting strong longer term momentum despite recent weakness around ¥1,706.
Expand your watchlist beyond Rigaku Holdings by scanning other precision hardware and semiconductor equipment plays in our hand picked 36 robotics and automation stocks.
Rigaku Holdings trades at a sizeable discount to analyst targets even after the recent bounce, yet the stock has been weak over 30 and 90 days. Is the market correctly pricing caution, or is it overlooking value ahead of a fresh product cycle?
Most Popular Narrative: 32.4% Undervalued
The most followed narrative on Rigaku Holdings compares a fair value of ¥2,523.61 to the recent close around ¥1,706. That gap sets up a very different view of the stock than the recent pullback suggests.
Rigaku is now effectively a semiconductor capital equipment company. Rigaku’s disciplined execution of the "Lab to Fab" strategy has grown the Semiconductor Process Control Instruments business’ share of operating income from 36.4% in FY12/23 to a guided ~49% in FY12/26, meaningfully shifting the earnings base toward the higher margin, higher growth semiconductor business. Although the heritage Multipurpose Analytical Instruments business is currently a big part of Rigaku, we believe that, over the medium term, the Semiconductor business will become an increasingly significant contributor to earnings as it scales rapidly, while the Multipurpose Analytical Instruments business continues to provide a stable and important foundation to support Rigaku’s growth.
The AstrisCorporateAdvisory narrative focuses on semiconductor process control earnings, a richer margin mix, and a long runway for X ray metrology demand. It raises questions about which revenue paths, profit margins, and future earnings multiples underpin that fair value for Rigaku Holdings.
Result: Fair Value of ¥2,523.61 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Rigaku Holdings still faces risks if semiconductor equipment orders slow or if product adoption in batteries and industrial customers takes longer than analysts currently expect.
Find out about the key risks to this Rigaku Holdings narrative.
Another View on Rigaku Holdings Valuation
While the AstrisCorporateAdvisory fair value suggests Rigaku Holdings is undervalued at around ¥2,523.61, the current P/E of 41.8x paints a different picture. That ratio is far above the 20.5x peer average and the 15.9x JP Electronic industry average, and it also exceeds the 26.1x fair ratio our models suggest the market could move toward. For investors, that gap points to valuation risk if sentiment or growth expectations cool, rather than a clear margin of safety.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of opportunity and risk around Rigaku Holdings feels finely balanced, take a moment to review the key data and decide where you stand. To frame that view against the market’s current concerns and optimism, start with the 1 key reward and 1 important warning sign.
Looking for more investment ideas beyond Rigaku Holdings?
If Rigaku Holdings has your attention, do not stop here. The next step is lining up a few more quality ideas so you always have options.
- Target stronger value opportunities by checking out a curated set of companies that appear attractively priced on fundamentals in the 23 high quality undervalued stocks.
- Prioritise resilience by scanning companies with healthier financial positions using the list of solid balance sheet and fundamentals (42 results).
- Get ahead of the crowd by reviewing promising businesses that the market may not be focused on yet through the 74 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com